BTG3 and systemic lupus erythematosus: Therefore, the authors postulate that monospecific anti‐DFS70 antibodies may be useful in the exclusion of the diagnosis of SLE in ANA‐positive patients with not classified arthritis, muscle pain, or unspecific skin lesions.14, 16